Roivant Sciences director Meghan Fitzgerald forfeited 1,743 shares at $40.94 per share, leaving her with 41,220 shares. The transaction represented about 4.1% of her prior holding and was classified under code F, indicating tax-related withholding, giving investors the stated size and remaining ownership of the director’s position.
Key Highlights
- The transaction was dated September 10, 2026.
- Transaction code F was reported for the action.
- Fitzgerald’s remaining Roivant Sciences holding was 41,220 shares.
Roivant Sciences Ltd. (NASDAQ: ROIV) director Meghan Fitzgerald forfeited 1,743 shares at $40.94 per share. The filing reported a director’s forfeiture of shares in the company.
September 10 Transaction Reported Under Code F
Meghan Fitzgerald is identified as a director of Roivant Sciences Ltd. The transaction date was September 10, 2026, and the reported transaction code was F.
Forfeiture Represented About 4.1% of Prior Holding
Fitzgerald’s reported ownership after the transaction was 41,220 shares. The forfeiture represented about 4.1% of her prior shareholding. The disclosed figures show the remaining stake and the stated relative size of the forfeiture within Fitzgerald’s prior holdings. Transaction code F denotes shares withheld or delivered to cover taxes or an exercise price.
FAQs
Q: What happened to Meghan Fitzgerald’s Roivant shares?
A: Roivant Sciences director Meghan Fitzgerald forfeited 1,743 shares at $40.94 per share. The transaction occurred on September 10, 2026, was reported under code F, and left her with 41,220 shares.
Q: Why did Roivant director Meghan Fitzgerald forfeit shares?
A: It reports that she forfeited 1,743 Roivant Sciences shares at $40.94 per share under transaction code F.
Q: How many Roivant shares did Meghan Fitzgerald retain?
A: Fitzgerald owned 41,220 Roivant Sciences shares after the transaction. The filing states that the 1,743-share forfeiture represented about 4.1% of her prior shareholding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.